Advertisement

Topics

Statins' potential to treat MS unrelated to the drug's cholesterol lowering effects

09:36 EDT 10 May 2019 | News-Medical.net

The widely prescribed statin, simvastatin, can medically help patients with secondary progressive Multiple Sclerosis - for reasons that might be unrelated to the drug's intended cholesterol lowering affects, a UCL study has found.

Original Article: Statins' potential to treat MS unrelated to the drug's cholesterol lowering effects

NEXT ARTICLE

More From BioPortfolio on "Statins' potential to treat MS unrelated to the drug's cholesterol lowering effects"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Statins
Statins (or HMG-CoA reductase inhibitors) are a class of drug used to lower cholesterol levels by inhibiting the enzyme HMG-CoA reductase, which plays a central role in the production of cholesterol in the liver. Increased cholesterol levels have been as...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...